Publications

Detailed Information

Influence of NQO1, ALDH2, and CYP2E1 genetic polymorphisms, smoking, and alcohol drinking on the risk of lung cancer in Koreans

DC Field Value Language
dc.contributor.authorEom, Sang-Yong-
dc.contributor.authorZhang, Yan Wei-
dc.contributor.authorKim, Sung-Hoon-
dc.contributor.authorChoe, Kang-Hyeon-
dc.contributor.authorPark, Jung-Duck-
dc.contributor.authorKim, Yong-Dae-
dc.contributor.authorKim, Heon-
dc.contributor.authorKang, Jong-Won-
dc.contributor.authorHong, Yun-Chul-
dc.contributor.authorLee, Kye Young-
dc.date.accessioned2012-06-08T07:43:03Z-
dc.date.available2012-06-08T07:43:03Z-
dc.date.issued2009-03-
dc.identifier.citationCANCER CAUSES & CONTROL; Vol.20 2; 137-145ko_KR
dc.identifier.issn0957-5243-
dc.identifier.urihttps://hdl.handle.net/10371/76923-
dc.description.abstractObjectives We investigated the association of genetic polymorphisms of NQO1, ALDH2, CYP2E1, and the combined genotype of these genes on lung cancer risk, and also evaluated the association after stratification by cumulative smoking amounts and alcohol drinking levels. Methods The case-control study was performed in 387 lung cancer patients and 387 age- and sex-matched cancer-free controls. Direct interview was conducted and the genotypes of NQO1, ALDH2, and CYP2E1 were investigated using PCR-RFLP or 50-nuclease activity assay. Results The proportion of individuals with occupational history of mining was significantly higher in cases than in controls. The risk of lung cancer was significantly lower in light-drinkers (<108 g/week) than non-drinkers. The NQO1 Pro/Ser + Ser/Ser genotype showed an increased risk for lung cancer with a marginal significance (OR = 1.35, 95% CI = 0.99-1.86) compared with NQO1 Pro/Pro genotype. In heavy-smokers, the combination of NQO1 Pro/Ser + Ser/Ser and CYP2E1 c1/c1 genotype was associated with a significantly increased risk for lung cancer (OR = 2.25, 95% CI = 1.14-4.43) compared with those of NQO1 Pro/Pro and CYP2E1 c1/c2 + c2/c2 genotype. We found a significant interaction between alcohol drinking level and the CYP2E1 genotype (P = 0.0227). Conclusions Our result suggests that the risk of lung cancer is affected by smoking, alcohol drinking, and the genetic polymorphism of NQO1. In particular, genetic polymorphisms for NQO1, CYP2E1, and ALDH2 synergistically with cumulative smoking amounts and alcohol drinking levels interact in the carcinogenesis of lung cancer in Koreans.ko_KR
dc.description.sponsorshipThis study was supported by the Eco-technopia
21 project of Ministry of Environment, South Korea.
ko_KR
dc.language.isoenko_KR
dc.publisherSPRINGERko_KR
dc.subjectLung cancerko_KR
dc.subjectGenetic polymorphismko_KR
dc.subjectAlcohol drinkingko_KR
dc.subjectSmokingko_KR
dc.titleInfluence of NQO1, ALDH2, and CYP2E1 genetic polymorphisms, smoking, and alcohol drinking on the risk of lung cancer in Koreansko_KR
dc.typeArticleko_KR
dc.contributor.AlternativeAuthor엄상용-
dc.contributor.AlternativeAuthor김성훈-
dc.contributor.AlternativeAuthor최강현-
dc.contributor.AlternativeAuthor이계영-
dc.contributor.AlternativeAuthor박정덕-
dc.contributor.AlternativeAuthor홍윤철-
dc.contributor.AlternativeAuthor김용대-
dc.contributor.AlternativeAuthor강종원-
dc.contributor.AlternativeAuthor김헌-
dc.identifier.doi10.1007/s10552-008-9225-7-
dc.citation.journaltitleCANCER CAUSES & CONTROL-
dc.description.citedreferenceYang M, 2007, LUNG CANCER, V57, P135, DOI 10.1016/j.lungcan.2007.03.005-
dc.description.citedreferenceMinegishi Y, 2007, CANCER, V110, P353, DOI 10.1002/cncr.22795-
dc.description.citedreferenceGresner P, 2007, LUNG CANCER, V57, P1, DOI 10.1016/j.lungcan.2007.02.002-
dc.description.citedreferenceVineis P, 2007, ANN ONCOL, V18, P1230, DOI 10.1093/annonc/mdm109-
dc.description.citedreferenceGao QX, 2006, J BIOL CHEM, V281, P20404, DOI 10.1074/jbc.M601785200-
dc.description.citedreferenceChao C, 2006, CANCER EPIDEM BIOMAR, V15, P979, DOI 10.1158/1055-9965.EPI-05-0899-
dc.description.citedreferenceSaldivar SJ, 2005, MUTAT RES-GEN TOX EN, V582, P71, DOI 10.1016/j.mrgentox.2004.12.010-
dc.description.citedreferenceBock CH, 2005, CARCINOGENESIS, V26, P381, DOI 10.1093/carcin/bgh314-
dc.description.citedreferencePAUL N, 2004, MUTAT RES, V555, P149, DOI DOI 10.1016/J.MRFMMM.2004.05.023-
dc.description.citedreferenceYokoyama T, 2003, CANCER EPIDEM BIOMAR, V12, P1227-
dc.description.citedreferenceWang JW, 2003, CANCER SCI, V94, P448-
dc.description.citedreferenceYang M, 2002, LUNG CANCER-J IASLC, V38, P15-
dc.description.citedreferenceDe Stefani E, 2002, LUNG CANCER-J IASLC, V38, P9-
dc.description.citedreferenceSunaga N, 2002, CANCER EPIDEM BIOMAR, V11, P730-
dc.description.citedreferenceKuper H, 2002, J INTERN MED, V251, P455-
dc.description.citedreferenceLewis SJ, 2001, LUNG CANCER-J IASLC, V34, P177-
dc.description.citedreferenceAgarwal DP, 2001, PATHOL BIOL, V49, P703-
dc.description.citedreferenceBandera EV, 2001, CANCER EPIDEM BIOMAR, V10, P813-
dc.description.citedreferenceYin L, 2001, LUNG CANCER-J IASLC, V33, P133-
dc.description.citedreferenceLI LX, 2001, CANCER EPIDEM BIOMAR, V10, P303-
dc.description.citedreferenceRoss D, 2000, CHEM-BIOL INTERACT, V129, P77-
dc.description.citedreferenceWang SL, 1999, LUNG CANCER-J IASLC, V26, P27-
dc.description.citedreferencePrescott E, 1999, AM J EPIDEMIOL, V149, P463-
dc.description.citedreferenceMARCHAND LL, 1999, CANCER EPIDEM BIOMAR, V8, P495-
dc.description.citedreferenceYokoyama A, 1998, CARCINOGENESIS, V19, P1383, DOI 10.1093/carcin/19.8.1383-
dc.description.citedreferenceChen WQ, 1998, CHEM RES TOXICOL, V11, P295-
dc.description.citedreferenceRadjendirane V, 1998, J BIOL CHEM, V273, P7382-
dc.description.citedreferenceHori H, 1997, J CLIN GASTROENTEROL, V25, P568-
dc.description.citedreferenceTraver RD, 1997, BRIT J CANCER, V75, P69-
dc.description.citedreferenceBANDERA EV, 1997, CANCER CAUSE CONTROL, V8, P819, DOI DOI 10.1023/A:1018456127018-
dc.description.citedreferenceTampo Y, 1996, ARCH BIOCHEM BIOPHYS, V334, P163-
dc.description.citedreferenceKim RB, 1996, J PHARMACOL EXP THER, V279, P4-
dc.description.citedreferencePeto R, 1996, BRIT MED BULL, V52, P12-
dc.description.citedreferenceKUEHL BL, 1995, BRIT J CANCER, V72, P555-
dc.description.citedreferenceDALY AK, 1994, ENVIRON HEALTH PERSP, V102, P55-
dc.description.citedreferenceGASDASKA PY, 1993, CANCER RES, V53, P5458-
dc.description.citedreferenceBECKETT WS, 1993, CLIN CHEST MED, V14, P1-
dc.description.citedreferenceKOOP DR, 1992, FASEB J, V6, P724-
dc.description.citedreferenceHAYASHI S, 1991, J BIOCHEM-TOKYO, V110, P559-
dc.description.citedreferenceGUENGERICH FP, 1991, CHEM RES TOXICOL, V4, P168-
dc.description.citedreferenceENOMOTO N, 1991, ALCOHOL CLIN EXP RES, V15, P141-
dc.description.citedreferenceHARADA S, 1989, ELECTROPHORESIS, V10, P652-
dc.description.citedreferenceKONO S, 1986, INT J EPIDEMIOL, V15, P527-
dc.description.tc10-
Appears in Collections:
Files in This Item:
There are no files associated with this item.

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share